Health Industries Research Companies (HIRC) has released its Summer 2004 Drug Formulary Positioning Supplement, a review of the health plan status of 200 major medications from 19 top pharmaceutical manufacturers. The Summer 2004 Drug Formulary Positioning Supplement profiles current drug formulary status, i.e., second tier (preferred), third tier (non-preferred), or no coverage for thirteen key medication classes including: ACE inhibitors, Allergy medications, Angiotensin II Receptor Blockers, Antibiotics, Antidepressants, Asthma medications, Beta Blockers, Calcium Channel Blockers, Cholesterol Reducers, Diabetic Agents, Osteoarthritis medications, Osteoporosis medications and Proton Pump Inhibitors.
